279 related articles for article (PubMed ID: 23735316)
1. Barriers to drug delivery in interventional oncology.
Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
[TBL] [Abstract][Full Text] [Related]
2. Extravasation of polymeric nanomedicines across tumor vasculature.
Danquah MK; Zhang XA; Mahato RI
Adv Drug Deliv Rev; 2011 Jul; 63(8):623-39. PubMed ID: 21144874
[TBL] [Abstract][Full Text] [Related]
3. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
Kirtane AR; Kalscheuer SM; Panyam J
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
[TBL] [Abstract][Full Text] [Related]
4. Improving drug delivery to solid tumors: priming the tumor microenvironment.
Khawar IA; Kim JH; Kuh HJ
J Control Release; 2015 Mar; 201():78-89. PubMed ID: 25526702
[TBL] [Abstract][Full Text] [Related]
5. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
Yang AD; Bauer TW; Camp ER; Somcio R; Liu W; Fan F; Ellis LM
Cancer; 2005 Apr; 103(8):1561-70. PubMed ID: 15754332
[TBL] [Abstract][Full Text] [Related]
6. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.
Chauhan VP; Stylianopoulos T; Boucher Y; Jain RK
Annu Rev Chem Biomol Eng; 2011; 2():281-98. PubMed ID: 22432620
[TBL] [Abstract][Full Text] [Related]
7. pH-sensitive drug-delivery systems for tumor targeting.
He X; Li J; An S; Jiang C
Ther Deliv; 2013 Dec; 4(12):1499-510. PubMed ID: 24304248
[TBL] [Abstract][Full Text] [Related]
8. Mechanical approaches to oncological drug delivery.
Carlisle R; Coussios CC
Ther Deliv; 2013 Oct; 4(10):1213-5. PubMed ID: 24116903
[No Abstract] [Full Text] [Related]
9. Targeting the molecular basis for tumour hypoxia.
Carroll VA; Ashcroft M
Expert Rev Mol Med; 2005 Apr; 7(6):1-16. PubMed ID: 15831177
[TBL] [Abstract][Full Text] [Related]
10. Drug penetration in solid tumours.
Minchinton AI; Tannock IF
Nat Rev Cancer; 2006 Aug; 6(8):583-92. PubMed ID: 16862189
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in cancer therapy: role of the microenvironment.
Galmarini CM; Galmarini FC
Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology applied to overcome tumor drug resistance.
Gao Z; Zhang L; Sun Y
J Control Release; 2012 Aug; 162(1):45-55. PubMed ID: 22698943
[TBL] [Abstract][Full Text] [Related]
13. Transport Barriers and Oncophysics in Cancer Treatment.
Nizzero S; Ziemys A; Ferrari M
Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
[TBL] [Abstract][Full Text] [Related]
14. Physical oncology: New targets for nanomedicine.
Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
[TBL] [Abstract][Full Text] [Related]
15. High interstitial fluid pressure - an obstacle in cancer therapy.
Heldin CH; Rubin K; Pietras K; Ostman A
Nat Rev Cancer; 2004 Oct; 4(10):806-13. PubMed ID: 15510161
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
17. Reengineering the Tumor Vasculature: Improving Drug Delivery and Efficacy.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):258-259. PubMed ID: 29606306
[TBL] [Abstract][Full Text] [Related]
18. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
19. [Can tumor hypoxia be turned into a chemotherapeutic advantage?].
Trédan O; Grantab R; Dumontet C
Bull Cancer; 2008 May; 95(5):528-34. PubMed ID: 18541517
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors.
Tomida A; Tsuruo T
Anticancer Drug Des; 1999 Apr; 14(2):169-77. PubMed ID: 10405643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
